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Current approaches towards understanding, diagnosing, and treating psychopathology 
in clinical practice typically occur through disorder specific conceptualisations of mental 
illness. Whilst this approach has demonstrated substantial clinical utility across a range of 
mental disorders (Barlow, 2014), the validity of discrete diagnostic classifications has been 
questioned, in light of the high symptom overlap present between disorders, and the high 
rates of diagnostic comorbidity present in clinical populations (Brown, Campbell, Lehman, 
Grisham, & Mancill, 2001; Clark & Taylor, 2009; Norton, 2006; Watkins, 2015). In addition, 
prior research suggests reduced treatment efficacy towards primary (Coplan, Aaronson, 
Panthangi, & Kim, 2015) and secondary diagnoses (Allen, Ehrenreich, & Barlow, 2005; 
Tsao, Mystkowski, Zucker, & Craske, 2005), for individuals presenting with comorbid 
presentations. Whilst existing disorder specific interventions such as CBT have demonstrated 
clinical utility across a range of internalising psychopathologies (see Hofmann, Asnaani, 
Vonk, Sawyer, & Fang, 2012), it may also be the case that disorder specific interventions 
have reduced clinical utility, within individuals who present to treatment, with comorbid 
diagnoses.  
In response to this issue, clinical research and practice has increasingly turned to 
transdiagnostic approaches to psychological intervention. Transdiagnostic approaches are 
thought to arise from three different orientations to treatment development (Sauer-Zavala et 
al., 2017). The first involves the universal application of therapeutic principles across 
multiple disorders whereby, for instance, similar cognitive therapy approaches might be 
applied across multiple disorders. In contrast, a “modular” approach involves clinicians 
choosing from a collection of strategies to generate a treatment which can be applied across 
disorders (Sauer-Zavala et al. p. 130). Finally, the “shared mechanisms” approach implies 
that there are common underlying mechanisms which should drive the development of 
interventions (Suaer-Zavala et al. p.130). While different in their approach to treatment 
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development, each of these transdiagnostic approaches may allow treatment to be delivered 
through one single protocol, increasing the efficiency and efficacy of treatment (Newby et al., 
2015; Sauer-Zavala et al., 2017). Although existing literature poses a range of potential 
mechanistically transdiagnostic factors, emotion regulation (ER) has continued to receive 
increased empirical support across internalising disorders. 
 Internalising psychopathology refers to the structural classification of disorders 
containing underlying dimensions of fear and distress, and reflects high negative affectivity 
(for review, see Krueger & Markon, 2006). Whilst typically characterised across anxiety and 
depression, more recent factor analyses research has extended this classification to include 
borderline personality disorder (Eaton et al., 2011; James & Taylor, 2008), and eating 
disorders (Forbush et al., 2010; Mitchell, Wolf, Reardon, & Miller, 2014). ER, which broadly 
refers to the ability to modulate or alter the intensity and duration of emotional states (Gross 
& Thompson, 2007), has been implicated across models of internalising psychopathology. 
These include major depressive disorder (Nolen-Hoeksema, Wisco, & Lyubomirsky, 2008), 
generalised anxiety disorder (Mennin, Holoway, Fresco, Moore, & Heimberg, 2007), social 
anxiety disorder (Kashdan & Breen, 2008), somatoform disorders (Waller & Scheidt, 2006), 
borderline personality disorder (Schulze et al., 2011), and eating disorders (Wild et al., 2007). 
As a putative mechanism of change in therapy, ER has been implicated across 
treatment modalities, as whilst Cognitive Behavioural Therapy (CBT; Beck, 1976) indirectly 
targets ER based processes, more recent third-wave psychological interventions such as 
Dialectical Behaviour Therapy (DBT; Linehan, 1993), Acceptance Commitment Therapy 
(ACT; Hayes, Strosahl, & Wilson, 1999), and mindfulness based interventions (Chambers, 
Gullone, & Allen, 2009) directly target ER as a component of treatment. In a recent 
systematic review analysing the involvement of ER across treatment, Sloan and colleagues 
(2017) identified ER across intervention modalities and disorder presentations, indicating that 
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ER is involved as a transdiagnostic factor both in the expression and treatment of 
psychopathology. However, many of the studies included in this review did not evaluate 
individuals presenting with comorbid presentations. This presents a limitation across research 
systematically reviewing single disorder treatment programs, as much of the real world 
clinical population presents with a variety of comorbid disorders, and as a result, many of 
these studies suffer from reduced ecological validity and clinical applicability (Ollendick, 
Jarrett, Grills-Taquechel, Hovey, & Wolff, 2008; Riosa, McArthur, & Preyde, 2011; Sloan et 
al., 2017). Thus, the current review aimed to examine the transdiagnostic role of ER as a 
treatment process, by evaluating the treatment efficacy of an ER based transdiagnostic 
intervention program; The Unified Protocol for Emotional Disorders (UP; Ellard, Fairholme, 
Boisseau, Farchione, & Barlow, 2010). 
The UP is a manualised ER-based transdiagnostic intervention program which focuses 
on addressing core emotion dysregulation across psychopathology to effect changes in a 
broad range of outcomes, including positive and negative affect. The UP holds particular 
appeal as a transdiagnostic approach given that it could be described as a “shared 
mechanisms” approach and is thus derived from underlying theories of psychopathology, in 
contrast to universal principles, which, although derived from theory, also rely on pre-
existing knowledge of how therapy should be conducted (Sauer-Zavala et al., 2017). Each of 
the five core modules aims to address different aspects of ER, for instance, the module 
focusing on cognitive flexibility fosters the development of cognitive reappraisal skills in 
contexts of high emotion and the tolerance-related modules allow the development of 
tolerance-skills, as opposed to unhelpful avoidance behaviours in emotion charged situations. 
There is also a module focused on psychoeducation and awareness of responding and coping, 
which is important for fostering emotional awareness as a foundation for improved ER, as 
well as two additional modules: 1) motivational interviewing/enhancement, 2) review and 
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relapse prevention modules, however these are considered to be only indirectly related to ER. 
In line with the framework of Gross’ (1998) process model, which describes ER as a set of 
strategies that aim to alter an emotional experience, the UP takes a cognitive behavioural 
approach towards developing adaptive ER skills (i.e. reappraisal, acceptance), and reducing 
maladaptive ER skills (i.e. suppression, avoidance). This is consistent with research 
implicating heightened patterns of maladaptive ER strategy engagement, and reduced 
adaptive ER strategy engagement, with the onset and maintenance of psychopathology 
(Aldao & Nolen-Hoeksema, 2012; Aldao, Nolen-Hoeksema, & Schweizer, 2010; Gross & 
Jazaieri, 2014).  
In addition, in line with Gratz and Roemer’s (2004) multidimensional model, the UP 
also builds towards core competencies of healthy ER, including an awareness and acceptance 
of emotional experiences, the ability to flexibly modulate the intensity and duration of 
emotional experiences, and a willingness to experience emotions within everyday life. This 
model is supported by research implicating deficits in these areas with heightened 
symptomology across internalising disorders (Sloan et al., 2017), and these deficits were 
greater within treatment seeking populations compared to healthy controls (Lavender et al., 
2015). As such, UP aims to reduce psychopathological expression, by shifting patterns in key 
ER based skills. Beyond psychopathology, the UP is also assumed to lead to improvements in 
overall functioning and quality of life (Ellard et al., 2010). The UP currently has empirical 
support across a range of internalising clinical presentations, including depression (Boswell, 
Anderson, & Barlow, 2014), anxiety disorders (Farchione et al., 2012), chronic pain (Allen et 
al., 2012), borderline personality disorder (Lopez et al., 2015), as well as across a range of 
anxiety based comorbidities (de Ornelas Maia, Sanford, Boettcher, Nardi, & Barlow, 2017; 
Hague, Scott, & Kellett, 2015; Laposa, Mancuso, Abraham, & Loli-Dano, 2017; Reinholt et 
al., 2017; Sauer-Zavala, Bentley, & Wilner, 2016) and is perhaps the most researched, 
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accessible and established of the various transdiagnostic approaches. While other 
transdiagnostic treatment approaches have also been developed, these other approaches have 
for the most part been restricted to the domain of anxiety disorders (e.g., Norton 2006; 
Schmidt et al., 2012) or are yet to attain the substantial transdiagnostic evidence base of the 
UP (e.g., Gros, 2014) and no other transdiagnostic approach places such central importance 
on difficulties in emotion regulation as a driver of psychopathology.  Whilst existing research 
has qualitatively examined the UP as a transdiagnostic intervention (see Norton & Paulus, 
2016) there are currently no quantitative meta-analytic reviews analysing these effects. 
Thus, the current systematic review and meta-analysis aimed to review published 
studies on the UP, in order to determine the degree to which the UP, as an ER focused 
intervention, leads to reductions across psychopathological outcomes. This will not only 
provide insight into the transdiagnostic efficacy of the UP as a manualised intervention, but 
will also help to determine whether ER and positive and negative affectivity show the 
expected improvements associated with the UP, which would be consistent with, though not 
conclusive of, its hypothesised role as a shared mechanism in psychopathology. In regards to 
the scope of research that will be considered in this current study, in line with the purpose of 
the UP, analysis will focus on internalising disorders (Ellard et al., 2010). Hence, our primary 
aim was to determine whether the UP is similarly efficacious across a range of internalizing 
disorders, regardless of the mode of administration or outcome measure used. In order to 
assess the assumption that these psychopathology related changes are associated with 
changes in ER and validate our primary research question, the secondary aim of the study 
was to evaluate the degree to which UP intervention leads to ER related changes, as indicated 
by measures reflecting changes in adaptive and maladaptive ER strategies. This will allow the 
current review to confirm a key prerequisite for the possibility that difficulties in ER act in a 
mechanism way in contributing to psychopathology, that is, an association between changes 
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in ER and changes in symptoms following the UP. Similarly, to the extent that positive and 
negative affectivity are thought to be key targets for the UP, we also sought to confirm that 
these variables also showed increases and decreases respectively, as predicted by the 
approach. A third aim of the current study was to evaluate secondary gains brought by the 
UP, which may provide insight as to the degree to which ER related effects translate to 
benefits such as reductions in functional impairment and improvements to quality of life. 
Method 
The review protocol was pre-registered in PROSPERO (CRD42018103874). 
Search Strategy 
To identify studies for possible inclusion, we conducted a comprehensive systematic 
search of electronic databases ‘PsycInfo’, ‘Pubmed’, ‘Medline’, ‘Embase’, and ‘Cumulative 
Index of Nursing and Allied Health Literature’ (CINAHL). The search strategy consisted of 
the following search terms;  
(i) The keyword “Unified Protocol” was used to specifically obtain studies 
relating to the intervention of interest 
(ii) The keywords “Affective Disorder*” or “Depressive Disorder*”, or “Anxiety 
Disorder*”, or “Major Depressive Disorder”, or “Social Anxiety Disorder”, or 
“Obsessive Compulsive Disorder”, or “Panic Disorder”, or “Post Traumatic 
Stress Disorder”, or “Generalised Anxiety Disorder”, were used, in order to 
obtain studies specifically targeting internalising psychopathology. Alternative 
phrases, words and spelling used, can be found in Supplementary Table 1. 
(iii) The keywords “Treatment”, or “Treatment Outcomes”, or “Treatment 
Effectiveness”, or “Treatment Evaluation”, or “Treatment Efficacy”, or 
“Experimental Design”, or “Empirical Study”, or “Clinical Trial”, or 
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“Intervention” were utilised, in order to obtain studies with appropriate 
outcome data.  
Inclusion/exclusion criteria 
Studies were included in the current review if: 
(i) Participants were over the age of 18, and diagnosed with at least one 
internalising disorder, or comorbid internalising disorders.. 
(ii) At least one validated self-report or clinician rated measure of internalising 
psychopathology was reported, with sufficient data for Hedges g effect size 
calculation for baseline verses post-treatment and/or follow-up data. 
(iii) Experimental research design, including randomised control trials, quasi-
experimental design, case series design, or other similar research designs 
specifically examining the UP, regardless of administration format. 
(iv) A diagnosis was confirmed by structured or semi-structured diagnostic 
interview. 
Studies were excluded from the current review, if they were; a) not published between 
the years 2010 and 2018, b) did not provide sufficient data relevant to internalising 
psychopathology outcome data, c) did not provide sufficient data to calculate effect sizes 
(e.g., pre- and post-treatment means, SDs and sample sizes in the case of calculating 
standardized mean differences), and d) if they did not confirm that all participants met the 
criteria for a mental disorder when assessed with a structured or semi-structured diagnostic 
interview. 
Identification and Screening Process 
Initial screening of studies involved removal of studies based on inclusion/exclusion 
criteria, through evaluation of titles and abstracts. Remaining studies (k= 110) were reviewed 
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by a secondary rater, and inclusion/exclusion criteria were again applied. Secondary rating 
demonstrated 94% agreement, and strong inter-rater reliability (Cohen’s Kappa= 0.81). 
Disagreements were mostly due to excluding criteria not being apparent in the titles/abstracts, 
and disagreements were resolved by discussion and mutual agreement on inclusion status. 
Data Extraction and Management 
Data extraction involved the collection of study characteristics, such as author names, 
sample details, study design, disorder presentations, psychopathology measures, and ER 
measures. Data was then transferred to the Comprehensive Meta-Analysis (version 3.3.070, 
Biostat, Inc.) software package, with relevant raw data (i.e., means, standard deviations, 
Cohen’s d, etc.), automatically transformed and standardised into Hedges g effect size data, 
for both uncontrolled (within study effects) and controlled (between study UP verses control 
group) data. Given that many studies reported multiple measures which loaded onto a single 
effect size construct (i.e., multiple psychopathology and emotion regulation measures), one 
single measure was selected, in order to maintain the assumption of independence for meta-
analyses (Lipsey & Wilson, 2001). Measures were selected based on the following criteria; a) 
clinician rated structured/semi-structured interviews of clinical severity were prioritised over 
self-report measures in order to establish greater reliability and validity of clinical severity, b) 
stronger psychometric properties were prioritised over measures with weaker psychometric 
properties, so as to maintain reliability and validity of measurement, c) measures which were 
included in a greater number of studies among our final sample of papers were prioritised 
over measures which were not already included in the analysis, in order to reduce measure 




The primary research question evaluating the treatment efficacy of the UP was 
operationalised using Hedges g effect size statistics for mean differences in symptom severity 
measures. The secondary research question evaluating the UP efficacy for ER change was 
operationalised by grouping adaptive and maladaptive ER engagement measures separately. 
The third research question evaluating secondary benefits to UP intervention was 
operationalised by grouping measures which were not directly related to the two aims above. 
For each of the above aims, Hedges g effect size data representing mean differences between 
baseline, post-intervention, and follow-up time points were generated for baseline verses 
follow-up data within the UP (i.e., uncontrolled effect), and between UP and control groups 
(i.e., controlled effect). Effect sizes were interpreted in accordance to Cohen’s (1977) 
recommendation, as small (< 0.2), medium (0.5), and large (> 0.8). 
Statistical Analyses 
A random effects model was used to calculate each Hedges g effect size and 
associated 95% confidence interval, as each study included in this analysis is assumed to be 
independent of one another, and thus variation in the true effect size is assumed to not be 
consistent or fixed. The Q-statistic and associated significance test was used to calculate 
heterogeneity between psychopathology constructs, and between each respective adaptive 
and maladaptive ER measure. The I2 statistic was used to evaluate the proportion of 
heterogeneity within each pooled effect size estimate, to measure the dispersion of effects. I2 
values were interpreted as the following; low (25%), moderate (50%), and high (75%) 
(Higgins, Thomson, Deeks, & Altman, 2003). A moderator analysis was also conducted via a 
meta-regression procedure, in order to examine sources of significant heterogeneity between 
psychopathology variables. Moderator variables were study design (RCT, quasi-
experimental, treatment response studies), study duration, and the categorical variable of 




In order to address the possibility of publication bias in the analysis, funnel plots with 
an index of study size plotted against effect size were produced, and visual assessment of 
symmetry was conducted (Rothstein, 2007). In line with recommendations based on the 
Cochrane Handbook for Systematic Reviews of Interventions, funnel plots for constructs with 
fewer than ten studies were not included, and fail-safe N statistics were not calculated due to 
unreliability (Sterne et al., 2011). Rather, analysis via through Duval and Tweedle’s Trim and 
Fill procedure allowed us to evaluate effect size estimates, after adjusting for potential 
publication bias (Duval & Tweedie 2000a, 2000b). Differences in study quality were also 
qualitatively assessed via the Joanna Briggs Institute (JBI) appraisal tool (Tufanaru, Munn, 
Aromataris, Campbell, & Hopp, 2017). 
Results  
Study Extraction and Study Characteristics 
From the initial 214 studies collected via the identification process, 15 studies were 
retained, and included into the analysis. A flow diagram of the screening process is presented 
in Figure 1. Of the 15 studies retained, a total of 1244 participants were measured from 
baseline to post-intervention across randomised control experimental designs (33%; e.g., 
Barlow et al., 2017), treatment response studies (33%; Bullis, et al., 2015), treatment 
response case series studies (21%; e.g., Ellard et al., 2012), and quasi-experimental designs 
(13%; e.g., De Ornelas Maia, Nardi & Cardoso, 2015). Sample sizes ranged from 3 to 616. 
The administration of the UP across these studies involved face-to-face (67%), group (27%), 
and online (6%) intervention, across an average of 15 sessions (SD= 3.2; range 12-20). From 
the total 15 studies included in the analysis, 47% included at least one measure of ER, and 
approximately 46% included a control reference group, comprised of treatment as usual 
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(14%), waitlist control (57%), and medication only (29%) comparison groups. For the 
majority of the included studies, clinical diagnosis was established via the The Anxiety 
Disorders Interview Schedule for DSM-IV: Lifetime Version (ADIS-IV-L; DiNardo, Brown, 
& Barlow, 1994) (40%), The Mini-International Neuropsychiatric Interview (M.I.N.I.; 
Lecrubier et al., 1997) (33%), The Structured Clinical Interview for DSM-IV (SCID-I/II/IV; 
First, Spitzer, Gibbon, & Williams, 1996) (20%), or other semi-structured psychiatric 
interviews (6%) (i.e. Thompson-Brenner et al., 2018). A summary of characteristics for each 
included study can be found in Table 1. 
Primary Research Question: UP Treatment Efficacy across Internalising Psychopathology 
A summary of uncontrolled effects across psychopathology measures for baseline 
verses post-intervention and follow-up can be found in Table 2, and the controlled effect can 
be found in Table 3. Each table also contains forest plots indicating effect size estimates, and 
corresponding 95% confidence intervals. Forest plots for each psychopathology construct can 
be found in Supplementary Tables 2(a) to 2(d). For the uncontrolled studies (Table 2), there 
was a range of between 2 and 12 studies, depending on disorder type, reporting baseline to 
post-treatment results, and between 3 and 5, for baseline to six-month follow-up. For 
controlled studies (Table 3), there were five studies within each disorder grouping reporting 
baseline to post-treatment results.  No study contributed more than one sample for the present 
analyses. Table 4 also includes three to five studies examining adaptive and maladaptive ER, 
and two studies at six-month follow-up time points. 
Uncontrolled effects. Baseline to post-intervention effect sizes across measures of 
psychopathology were generally in the large effect size range, with efficacy being strongest 
within obsessive compulsive disorder, and weakest within depression. The global 
psychopathology effect, which is a measure of global psychopathology symptom severity, 
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was also in the large effect range at baseline verses post-treatment. Across disorders, the 
efficacy of the UP continued to reduce psychopathological severity at six-month follow-up, 
with the greatest follow-up symptom improvement occurring for panic disorder with 
agoraphobia (gdiff = -.44), and the weakest follow-up improvement occurring for social 
anxiety  disorder (gdiff = -.02). Significant heterogeneity was evident within all symptom 
domain groups except BPD, generalized anxiety disorder (GAD), panic disorder with 
agoraphobia (PDA), posttraumatic stress disorder (PTSD) and global psychopathology 
(p’s>0.05) for the baseline to posttreatment comparisons and for all comparisons except 
GAD, PDA, PTSD, social anxiety disorder (SAD) and global psychopathology (for all 
baseline to 6mth comparisons). 
Controlled effects. At post-intervention, the UP had significantly greater treatment 
efficacy compared to TAU, waitlist, and medication control groups, and this effect was 
moderate and large for depression and anxiety, respectively. Significant heterogeneity not 
was evident within all symptom domain groups except anxiety and depression (p’s>0.05) for 
the baseline to posttreatment comparisons and there was no heterogeneity evident for any 
baseline to 6mth controlled comparisons. 
Meta-regression. A meta-regression was conducted to examine possible moderating 
effects for heterogeneity for the controlled effect for anxiety and depression respectively at 
baseline verses post-intervention. A model accounting for administration format, and study 
duration was not significant for anxiety (Q=0.55, df=3, p=0.91) or depression symptoms 
(Q=0.74, df=3, p=0.86). Caution however is warranted in interpreting this effect, due to low 
study sample size and the small number of studies included in each regression. Scatterplots 
for each moderator variable on psychopathology outcomes can be found in Supplementary 
Figures 2(a) to 2(d). 
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Secondary Research Question: UP Treatment Efficacy on Emotion Regulation and Positive 
and Negative Affect 
A summary of the random effects model for uncontrolled adaptive and maladaptive 
ER effects across baseline verses post-intervention and follow-up, can be found in Table 4. 
Each table also contains forest plots indicating effect size estimates, and corresponding 95% 
confidence intervals. Forest plots for adaptive and maladaptive ER effect sizes can be found 
in Supplementary Tables 3(a) to 3(d). A comparison to control group was not conducted, due 
to low study sample size (k=1). 
Adaptive ER. Adaptive ER measures comprised of the Southampton Mindfulness 
Questionnaire (SMQ; Chadwick et al., 2008) and the Emotion Regulation Questionnaire – 
Reappraisal Subscale (ERQ-R; Gross & John, 2003). At post-intervention, the UP led to 
significant moderate increases in adaptive ER engagement, and this effect was no longer 
significant at six-month follow-up. There was significant heterogeneity found between 
adaptive ER measures at baseline verses post-intervention (Q= 7.75, df= 2, p= .02), and no 
significant heterogeneity at baseline verses six-month follow-up (Q= .29, df= 1, p= .59). A 
meta-regression was not conducted to examine this heterogeneity, due to the low number of 
studies included in the analysis. 
Maladaptive ER. Maladaptive ER measures included the Multidimensional 
Experiential Avoidance Questionnaire (MEAQ; Gámez, Chmielewski, Kotov, Ruggero & 
Watson, 2011), the Emotion Regulation Questionnaire – Suppression Subscale (ERQ-S; 
Gross & John, 2003), and the Difficulties in Emotion Regulation Scale (DERS; Gratz & 
Roemer, 2004). At post-intervention, the UP significantly and moderately decreased 
maladaptive ER strategies, however retention of treatment effects at six-month follow-up 
were unable to be calculated, due to the low number of studies included in the analysis (k= 1). 
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There was significant heterogeneity found between maladaptive ER measures at baseline 
verses post-intervention (Q= 16.88, df= 5, p= .05). Given the small number of studies 
reporting maladaptive ER outcomes, we conducted two separate meta-regression analyses 
with intervention duration the sole predictor in the first analysis and treatment delivery 
format entered as the sole predictor in the second analysis. Neither duration of intervention 
nor delivery format (individual face-to-face vs group treatment vs online) accounted for this 
heterogeneity (p’s>0.05).  We note that there appeared to be pronounced variation in the 
baseline to post-intervention effect sizes depending on the outcome measure used, with 
moderate to large reductions in MEAQ (g=-0.76, CI=-0.91, -0.61, p<0.01 and -1.03, CI=-
1.73,-.33, p<0.01) and DERS (g=-1.00, CI=-1.89, -0.11, p=.03 & g=-1.35, CI=-2.23, -0.47, 
p<0.01), but only negligible reductions in ERQ-S (g=-0.02, CI=-0.66, 0.62, p=0.95). 
Positive and Negative Affect. The lower section of Table 4 summarises the results 
for positive and negative affect respectively. The uncontrolled studies of negative affect 
indicated reductions in negative affect at both post treatment and six month follow-up. For 
positive affect, there were significant reductions by post treatment, although improvement 
was not evident by six-month follow-up.Forest plots for positive and negative affect effect 
sizes can be found in Supplementary Tables 3(e) to 3(h). 
Third Research Question: Secondary Treatment Effects 
A summary of the random effects model for the controlled baseline verses post-
intervention and follow-up effect sizes for functional impairment and quality of life can be 
found in Table 5. Each table also contains forest plots indicating effect size estimates, and 
corresponding 95% confidence intervals. Forest plots for each secondary measure can be 
found in Supplementary Tables 4(a) to 4(c). 
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Uncontrolled effects. There were significant and moderate to large effect sizes 
obtained across additional clinical measures. These included reductions in functional 
impairment and increases in quality of life. These therapeutic benefits were retained across 
time up to the six-month follow-up, for each respective construct quality of life (g=0.21, 
p=0.10).  
Controlled effects. Due to the low number of studies available for comparison with 
control groups, functional impairment was the only construct that was included in the 
analysis. Compared to control, UP intervention had significantly and moderately reduced 
functional impairment at baseline verses post-intervention (k = 4, g= -.70, CI= -.95, -.46, SE= 
.13, p< .001), but insufficient studies available for baseline to six-month follow-up 
comparisons. 
Publication Bias 
Funnel plots generated across for anxiety and depression baseline to post-intervention 
can be found in Supplementary Figures 1(a) and 1(b). 
Psychopathology measures. Duval and Tweedle’s Trim and Fill procedure did not 
indicate corrections for publication bias across each respective uncontrolled baseline to post-
intervention psychopathology measure, except for GAD, which indicated an adjusted effect 
size estimate from g= -0.97 to g= -0.86 (one study removed) and OCD, which changed from 
g=-1.23 to g=-1.03 (one study removed). Together, this suggested an unlikely or minimal 
publication bias effect. 
ER measures. For uncontrolled studies of adaptive ER strategy measures from 
baseline to post-intervention, Duval and Tweedle’s Trim and Fill procedure indicated an 
adjusted effect size estimate from g= .57 to g= .51 (one study removed). There was no 
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adjustment indicated for maladptive ER strategies. This collectively suggested unlikely or 
minimal publication bias effect, across both adaptive and maladaptive ER measures.  
Risk of Bias Assessment 
In order to comprehensively review the scope of UP research, the current study 
included research with different levels of quality. The majority of research maintained a high 
standard of reporting, with minor flaws in reporting specific randomisation and sampling 
procedures. There were no substantial discrepancies in quality between included studies. 
More detailed results for the JBI critical appraisal tool can be found in Supplementary 
Material 1. 
Discussion 
In the present meta-analytic review, we evaluated the transdiagnostic treatment 
efficacy of the UP across internalising disorders, as well as the degree of change in ER 
strategy engagement, in order to gain insight into the clinical applicability of ER as a shared 
mechanisms factor within psychological intervention. Across a total of 15 studies and a 
clinical sample of 1244 participants, baseline to post-intervention UP effects demonstrated 
large effect size reductions across measures of generalised anxiety disorder, obsessive 
compulsive disorder, panic disorder with/without agoraphobia, social anxiety disorder, post-
traumatic stress disorder, and borderline personality disorder. Furthermore, these large 
symptom reductions were found to remain stable across a 6-month time-period. In addition, 
compared to inactive control conditions, the UP demonstrated moderate and large effect size 
reductions across measures of depression and anxiety, respectively. However, the relative 
benefit of these effects at 6-month follow-up are unclear, as analysis was limited to 
evaluating only a single study. Nonetheless, results of the current analysis support the 
transdiagnostic efficacy of the UP across internalising disorders, however further research is 
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required to determine whether these treatments are more beneficial than control conditions at 
6-month follow-up. 
Methodological limitations of the primary studies, including a wide range of relatively 
generic CBT protocols used for single intervention approaches, as well as relatively few 
manualized interventions, precluded us from making inferences about the outcomes from the 
UP when compared with disorder-specific protocols. However, effect sizes obtained in our 
review were comparable to those of previous meta-analyses evaluating the treatment efficacy 
of CBT, whereby large uncontrolled effects, and moderate to large controlled effects, were 
reported across anxiety and depression measures (Butler, Chapman, Forman, & Beck, 2006; 
Hofmann & Smits, 2008; Tolin, 2010; Stewart & Chambless, 2009). It is important to note 
that the conceptual foundations of the UP regarding extinction learning via avoidance 
reduction and building cognitive flexibility via identifying and altering maladaptive 
cognitions, are rooted in CBT practice, however are adapted to explicitly focus on the 
functional nature of emotions and the cognitive-behavioural reactions against emotional 
experiences (Ellard et al., 2010). Thus, the similarity in effect sizes obtained between meta-
analyses may indicate that shifting key CBT based processes towards a dialogue of emotion 
focused language, emphasising emotional experiences and patterns of cognitive and 
behavioural responses to emotion, may provide comparable treatment benefits to standard 
CBT.  
In addition, compared to single disorder interventions which directly target ER within 
treatment, current effect size estimates for anxiety and depression were larger than those 
previously reported by mindfulness based interventions (Khoury et al., 2013), were greater in 
reducing depressive symptom severity compared to DBT (Panos, Jackson, Hasan, & Panos, 
2014), and was marginally less efficacious for global psychopathology effect size estimates 
compared to ACT (A-tjak et al., 2015; Hofmann, Sawyer, Witt, & Oh, 2010; Öst, 2014). This 
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may also indicate comparable efficacy to other prominent third-wave emotion focused 
interventions. Further randomised control trial studies evaluating the efficacy between 
treatment modalities is thus required to further evaluate these relationships.  
Comparability of outcomes aside, a potential advantage of the UP when compared 
with standard CBT approaches which do explicitly emphasise emotion regulation skills (e.g.,  
Andrews, Creamer, Crino, Hunt, Lampe, & Page, 2002; Greenberger & Padesky, 1995) is 
that the UP may have additive value in providing clients with broader, transdiagnostic skills 
in this regard. This has previously been identified as a limitation to standard CBT approaches 
(Coplan et al., 2015; Newby et al., 2015). Unfortunately, we were not able to examine the 
extent of such benefits in the present review, but further studies might aim to compare the 
outcomes of UP compared to standard CBT for secondary or co-occurring symptoms. 
The secondary aim of the study was to evaluate a key assumption underlying our 
primary research question, namely, to what extent the UP leads to change across measures of 
adaptive and maladaptive ER strategy engagement. Results revealed that for measures of 
adaptive ER strategy engagement, significant moderate effect size improvements were 
evident for the mindfulness-related skills of awareness and acceptance of emotions, and 
cognitive reappraisal of negative emotions, at post-intervention. Unfortunately, only two of 
the included studies reported a 6-month follow up. For these studies, improvements appeared 
to be attenuated at 6-month follow-up and only small to moderate in magnitude. Additional 
follow-up studies will confirm whether ER skills can be developed and maintained following 
treatment in line with the stated objectives of the approach.   
Similarly, UP interventions also led to significant moderate effect size reductions in 
maladaptive ER strategies of experiential avoidance of emotions, suppression of emotional 
experiences, and difficulties in employing emotion based skills, at post-intervention. 
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Unfortunately however, the lack studies reporting follow-up data precluded the current 
analysis from evaluating whether these benefits were retained across time. Further research 
may examine whether some ER skills show persisting greater persistence of benefit from the 
UP than others. Nonetheless, the current state of the literature supports the assumption that, 
overall, the UP leads to significant changes in ER. This is highlighted by change across the 
core competencies of the protocol regarding adaptive ER improvements in the awareness, 
acceptance, willingness and cognitive flexibility towards emotional experiences. Likewise, 
reductions in maladaptive ER engagement in emotional avoidance, emotional suppression, 
and difficulties associated with ER strategy use were also evident. 
There were moderate to large improvements in the frequency of positive and negative 
affect experienced across the post-intervention and follow-up intervals. Considering that 
increased frequency of negative affect experienced has been associated with maintaining 
factors of psychopathology such as impaired cognitive processing, reduced coping, increased 
social withdrawal, and reduced behavioural repertoire (Fredrickson, 2001; Fredrickson & 
Branigan, 2005; Watson, Clark, & Tellegen, 1998), it may also be the case that improvements 
in negative affectivity indirectly relate to reductions in symptom severity across internalising 
diagnoses, as demonstrated by our primary research question. 
In regards to the third aim of the study, regarding secondary benefits occurring as a 
consequence of UP intervention, results indicated that there were large improvements in 
functional impairment and quality of lifeCompared to control groups, large reductions in 
functional impairment were evident at the post-intervention and six-month follow-up time 
points. These results not only highlight secondary benefits of the UP intervention, but also 
contribute to the existing body of literature implicating ER interventions with improvements 
in quality of life and daily functioning (see DeVibe et al., 2017).  
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Our review provides detailed information regarding the effectiveness of the UP as a 
transdiagnostic intervention. However, our conclusions need to be tempered by a number of 
limitations. First, we need to be hesitant in drawing inferences regarding the relative effect 
compared to other treatment modalities, due to the lack of research comparing these effects 
within the field. The current study was also unable to draw causal inferences between ER 
change and reductions in psychopathology severity, as the relative lack of research which 
reported ER related outcomes in the context of psychopathology outcomes, constrained our 
ability to conduct a structured mediational analysis (Fritz & MacKinnon, 2007). Thus, further 
verification of the assumption that the UP is related to ER change is required, especially 
given that our study did not require the presence of validated ER measures for inclusion. 
Thus, it is recommended that future UP research include measures of changes in ER. Ideally, 
this should also involve comparisons of changes in ER between treatment conditions so as to 
better identify underlying mechanisms of change, and how this may differ between 
interventions. An alternative possibility: that changes in ER might in fact follow from 
changes in psychological symptoms, should also be explored. Second, the studies included in 
this review which reported ER measures did not analyse important modifying factors 
implicated in the effectiveness of ER interventions, such as the context (Eftekhari, Zoellner, 
& Vigil, 2009; Gratz, Weiss, & Tull, 2015), and the interaction between co-occurring ER 
processes (Aldao & Nolen-Hoeksema, 2010, 2012; John & Gross, 2007). For instance, while 
re-appraisal may be helpful when a person fails an exam, it might not be as helpful in a 
different context, such as when a person is grieving the loss of a loved one. Further, multiple 
ER strategies may at times be deployed simultaneously and interact with each other in either 
compounding or subduing emotional states (Aldao & Nolen-Hoeksema, 2010; Aldao & 
Nolen-Hoeksema, 2012; John & Gross, 2007). Conceivably, the primary diagnosis or 
constellations of comorbidity in a person may also be important moderators, however the 
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variable reporting practices in the primary studies precluded a formal analysis of this 
possibility. Thus, we are unable to speculate on contextual factors or the complexity of 
interdependent ER processes on the basis of this review. The scope of our review was also 
limited to studies where participants met diagnostic criteria for an internalising disorder. 
Further research should aim to ascertain whether similar outcomes are achieved for sub-
clinical populations. Finally, we were unable to determine whether particular participant 
diagnoses were associated with outcomes from the UP as primary studies often included a 
mix of disorder categories in their samples, precluding us from conducting the requisite 
analyses. 
The above limitations notwithstanding, the current review was the first to 
systematically evaluate the UP as a transdiagnostic ER based intervention. It adds to the 
growing body of literature examining transdiagnostic processes underlying clinical 
interventions. Our extensive review, conducted across internalising disorders, derived from 
gold standard clinician-rated measures, across both controlled and uncontrolled studies 
provides confidence that the UP is an efficacious protocol with transdiagnostic value and 
apparent stability of gains across time. For clinicians, the UP thus appears to be a flexible and 
valuable approach for clients presenting with a range of internalising psychopathologies. 
Whilst improvements in ER skills appear to coincide with symptom reductions when the UP 
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Records identified through database search 
conducted on 18/05/2018 
























Records remaining after duplicates removed 
(n = 110) 
Records screened for 
inclusion criteria 
(n = 33) 
 
Records excluded 
(n = 78) 
• Child/adolescent sample (n= 12) 
• Non-empirical design (n= 7) 
• Non UP related study (n= 8) 




    
 
Records screened for 
exclusion removed 
(n = 15)  
Full-text articles excluded, with 
reasons (n = 17) 
• Planned protocols without 
results reported (n= 5) 
• Insufficient/inappropriate data 
reported (n= 9) 
• Subclinical population (n= 1) 





Studies included in 
qualitative synthesis 
(n = 15) 
Studies included in 
quantitative synthesis 
(meta-analysis) 
(n = 15) 
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Table 1. Characteristics of Studies Included in the Meta-Analysis Evaluating the Transdiagnostic Effect of the Unified Protocol.  












design - 16 session face-
to-face UP intervention 
vs. WLC*, with 6MFU 
Primary Diagnoses: GAD, 





Bullis et al., 2015 11 treatment 
seeking adults 




study - 12 session group 
based UP intervention 
 
Primary Diagnoses: 
Dysthymia, SAD, Anxiety 
NOS, 
 
Comorbid Diagnoses: SAD, 
GAD, , SP, ADHD, MDD, 
PTSD, Depression NOS, 
Anxiety NOS, Alcohol 
abuse, Trichotillomania, 
OASIS, ODSIS MEAQ PANAS, 
WSAS, Q-LES-
Q 
de Ornelas Maia, 
Braga, Nunes, Nardi, 
& Silva, 2013 
16 Brazilian adults 
recruited via public 
health service 
Treatment response 
study - 12 session group 
based UP intervention 
 
Primary Diagnoses: MDD 
 
Comorbid Diagnoses: GAD, 
PD, SAD, PTSD 
BAI, BDI N/A ASEX, WHO-
QoL  
de Ornelas Maia, 






design – 12 session 
group UP + medication 
TAU vs. medication 
TAU 





BAI, BDI N/A N/A 
39 
 
Table.1 (continued)       






Ellard et al., 2017 29 adults recruited 
via a Massachusetts 
Clinic 
RCT experimental 
design –  
18 session face-to-face 














& Barlow, 2012 
3 treatment seeking 
adults 
Treatment response case 
series – 15 session face-






PTSD, PDA, SAD, PTSD, 








& Barlow, 2010 
18 (study 1) and 15 
(study 2) treatment 
seeking adults 






Two treatment response 
pilot studies – 17-18 
session face-to-face UP 
intervention, with 
6MFU 
Primary Diagnoses: GAD, 
SAD, OCD, PDA, 
Co-principal Diagnoses: 
GAD/PD, GAD/SAD 
Comorbid Diagnoses: GAD, 
SAD, PDA, MDD, SP, 
Hypochondriasis, Anxiety 






N/A PANAS, WSAS  
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Table.1 (continued)       






Farchione et al., 
2012 
37 treatment 




design – 18 session 
face-to-face UP 
intervention vs. WLC 
Primary Diagnoses: GAD, 






Comorbid Diagnoses: MDD, 









N/A PANAS, WSAS 




design – 18 session 
face-to-face UP 
intervention vs. WLC, 
with 3MFU 
Primary Diagnoses: MDD, 















Table.1 (continued)       










6 Iranian adults 
referred for clinical 
trial 
Multiple baseline 
experimental case series 
– 16-20 session face-to-
face UP intervention 
 
Primary Diagnosis: BPD 
 
Comorbid Diagnoses: MDD, 
anxiety disorder 
 
BPI DERS N/A 





study - 15 session group 
based UP intervention 
 
Primary Diagnoses: PD, 
PDA, SAD, GAD 
Comorbid Diagnoses: PDA, 
SAD, GAD, SP, MDD, 
dysthymia, ADHD, SDD, 








Bentley, & Wilner, 
2016 
5 treatment seeking 
adults 
Treatment response case 
series – 16-20 face-to-
face session UP 
intervention 
Primary Diagnoses: BPD 
 
Comorbid Diagnoses: GAD, 
MDD, SAD 
DASS-A , DASS-




Huynh, Brooks, & 
Lowe, 2018 
616 female cross-
site ED hospital 
inpatients 
Quasi-experimental 
design -face-to-face UP 
intervention vs. WLC 
Primary Diagnoses: ED 
Comorbid Diagnoses: 










Table.1 (continued)       













study - 10 week online 
based UP intervention, 
with 6MFU 
Primary Diagnoses: GAD, 
SAD, MDD, PD/A, PTSD, 
SP, OCD 
Comorbid Diagnoses: GAD, 






ERQ WSAS, QOLI,  
APS-R 
Note: Measures include only those selected for analysis. See methods section for selection criteria. 
Treatments: TAU= treatment as usual RCT = randomised control trial, WLC = waitlist control, UP = unified protocol.  
Participants: ADHD = attention deficit hyperactivity disorder, APD= Avoidant Personality Disorder, BD = bipolar disorder, BPD = borderline personality disorder, ED = 
eating disorder, GAD= generalised anxiety disorder, MDD = major depressive disorder, NOS = not otherwise specified, OCD = obsessive compulsive disorder, PD = panic 
disorder, PDA = panic disorder with agoraphobia, PTSD = posttraumatic stress disorder, SAD = social anxiety disorder, SP = specific phobia. 
Measures: ACS = Affective Control Scale, ADIS-IV CSR = Anxiety Disorders Interview Schedule for DSM-IV Clinical Severity Rating, APS-R = Almost Perfect Scale-
Revised, ASEX = Arizona Sexual Experiences Scale, BAI = Beck Anxiety Inventory, BDI-II = Beck Depression Inventory-II, BPI = Borderline Personality Inventory, CGI-
GAF = Clinical Global Impression – Global Assessment of Functioning, CGI-S = Clinical Global Impression- Severity Scale, DERS = Difficulties in Emotion Regulation 
Scale, ERQ= Emotion Regulation Questionnaire, GRID-HAMD = GRID-Hamilton Depression Rating Scale, HAM-A = Hamilton Anxiety Rating Scale, HAM-D-17 = 
Hamilton Depression Rating Scale - 17-item version, MEAQ = Multidimensional Experiential Avoidance Questionnaire, OASIS = Overall Anxiety Severity and Impairment 
Scale, ODSIS = Overall Depression Severity and Impairment Scale, PANAS = Positive and Negative Affect Schedule, PCL-5 = Posttraumatic Stress Disorder Checklist for 
DSM-5, PDSS-SR = Panic Disorder Severity Scale–Self-Report Version, PSWQ = Penn State Worry Questionnaire, Q-LES-Q = Quality of Life Enjoyment and Satisfaction 
Questionnaire, QOLI = Quality of Life Inventory, SDS = Sheehan Disability Scale, SIGH-A =Structured Interview Guide for the Hamilton Anxiety Scale, SIGH-D = 
Structured Interview Guide for the Hamilton Depression Scale, SMQ = Southampton Mindfulness Questionnaire , SPIN = Social Phobia Inventory, WHO-5 = World Health 
Organisation- Five Well-Being Index, WHO-QoL = World Health Organisation – Quality of Life Scale, WSAS = Work and Social Adjustment Scale, YBOCS = Yale 
Brown Obsessive Compulsive Scale. 
Comparison: 3mfu = three-month follow-up, 6mfu = six-month follow-up. 12mfu = twelve-month follow-up, 18mfu = eighteen-month follow-up. 






Table 2. Uncontrolled Effect of the Unified Protocol across Internalising Disorders, and 95% Confidence Intervals. 
Symptom 
domain Comparison k 
Hedges g 
 (Lower CI, 
Upper CI) 
Variance Std. Error Z-value p-Value I
2 
Summary Effect Size Forest Plot* 
 
 -3.0   -2.5   -2.0   -1.5    -1.0     -0.5     0 
Anxiety Baseline vs.  
post treatment 12 
-.99  
(-1.30, -.68) .03 .16 -6.24 <.001 85.54 
 
 Baseline vs. 
6mfu 5 
-1.25  
(-1.80, -.69) .08 .28 -4.40 <.001 92.47 
 
Depression Baseline vs.  
post treatment 12 
-.92  
(-1.21, -.64) .02 .14 -6.43 <.001 80.00 
 
 Baseline vs. 
6mfu 5 
-1.07 
 (-1.56, -.58) .06 .25 -4.27 <.001 90.19 
 
GAD Baseline vs.  
post treatment 5 
-.97 
 (-1.23, -.70) .02 .14 -7.11 <.001 12.53 
 
 Baseline vs. 
6mfu 3 
-1.18 




Baseline vs.  
post treatment 5 
-1.23 
 (-1.91, -.55) .12 .35 -3.56 <.001 80.19 
 
 Baseline vs. 
6mfu 3 
-1.60 







Table 2. (continued) 
Symptom 
domain Comparison k 
Hedges g 
 (Lower CI, 
Upper CI) 
Variance Std. Error Z-value p-Value I
2 
Summary Effect Size Forest Plot* 
 
-3.0   -2.5   -2.0    -1.5     -1.0      -0.5      0 
PD Baseline vs.  
post treatment 3 
-1.17  





 (-2.06, -.47) .17 .41 -5.87 <.001 82.95 
 
PDA Baseline vs.  
post treatment 4 
-.93 





 (-1.83, -.91) .06 .23 -5.87 <.001 0 
 
SAD Baseline vs.  
post treatment 5 
-1.05  





(-1.35, -.80) .02 .14 -7.53 <.001 5.85 
 
BPD Baseline vs.  
post treatment 2 
-1.05 
 (-1.63, -.47) .09 .30 -3.54 <.001 0  
GPE** Baseline vs. 
post treatment 4 
-1.27 
 (-1.60, -.93) .03 .17 -7.43 <.001 56.17  
 Note: Symptom domains and comparison points were not reported if they contained less than two studies in analysis. 
Disorders: GAD= Generalised Anxiety Disorder, PD = Panic Disorder, PDA = Panic Disorder with Agoraphobia, SAD= Social Anxiety Disorder, PTSD = 
Post Traumatic Stress Disorder, BPD = Borderline Personality Disorder, GPE= Global Psychopathology Effect. 
Comparison: 6mfu = six-month follow-up. 
k = number of individual studies included in each summary effect size. 
* Summary effect size forest plot comprises of Hedges g effect size statistic and corresponding 95% confidence interval, and does not reflect a separate meta-
analysis conducted.  





Table 3. Controlled Effect of the Unified Protocol across Internalising Disorders, and 95% Confidence Intervals. 
Symptom 
domain Comparison k 
Hedges g 
 (Lower CI,  
Upper CI) 
Variance Std. Error Z-value p-Value I
2 
Summary Effect Size Forest Plot* 
 
-2.5    -2.0    -1.5       -1.0      -0.5         0     
Anxiety Baseline vs. 
post treatment 5 
-.81  
(-1.29, -.34) .06 .24 -3.37 .001 84.11 
  
Depression Baseline vs. 
post treatment 5 
-.57 
 (-.92, -.21) .03 .18 -3.14 .002 71.94 
 
Note: Disorders and comparison points were not reported if they contained less than two studies in analysis. . 
k = number of individual studies included in each summary effect size. 
* Summary effect size forest plot comprises of Hedges g effect size statistic and corresponding 95% confidence interval, and does not reflect a 













Table 4. Uncontrolled Effect of the Unified Protocol across Emotion Regulation Strategies and Positive and Negative Affect, with 95% 
Confidence Intervals. 
Measure 
Type Comparison k 
Hedges g  
(Lower CI, 
Upper CI) 
Variance Std. Error Z-value p-Value I
2 
Summary Effect Size Forest Plot* 
 




post treatment 3 
.57 










post treatment 6 
-.65 
 (-.98, -.33) .03 .17 -3.95 <.001 70.38 
 




post treatment 5 
.48 
 (.20, .76) .02 .14 3.38 <.001 0 
 
 Baseline vs. 6mfu 2 
.46 





post treatment 5 
-.62  
(-.84, -.41) .01 .11 -5.67 <.001 0 
 
 Baseline vs. 
6mfu 2 
-.79 
 (-1.15, -.44) .03 .18 -4.34 <.001 0 
 
Note: Comparison points were not reported if they contained less than two studies in analysis. A comparison between the UP and control could 
not be made, due to all comparison points having less than two studies involved in analysis.  
Comparison: 6mfu = six-month follow-up. ER = Emotion regulation. 
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k = number of individual studies included in each summary effect size. 
* Summary effect size forest plot comprises of Hedges g effect size statistic and corresponding 95% confidence interval, and does not reflect a 





Table 5. Uncontrolled Effect of the Unified Protocol for Secondary Treatment Effects, and 95% Confidence Intervals. 
Construct Comparison                       k 
Hedges g  
(Lower CI,  
Upper CI) 
Variance Std. Error Z-value p-Value I
2 
Summary Effect Size Forest Plot* 
 




post treatment 7 
-.91 










post treatment 4 
.83 
(.10, 1.57) .14 .38 2.22 .027 0 
 
Note: Constructs and comparison points were excluded if they contained less than two studies in analysis. Excluded constructs include; Affect 
Appraisal, Hopelessness, Perfectionism, Sexual Dysfunction, Subjective Wellbeing, and Suicidal Ideation. 
Comparison: 6mfu = six-month follow-up. 
k = number of individual studies included in each summary effect size. 
* Summary effect size forest plot comprises of summary effect size statistic and corresponding 95% confidence interval, and does not reflect a 
separate meta-analysis conducted.  
 
